Co-Authors
This is a "connection" page, showing publications co-authored by Ole Søgaard and Peter Breining.
Connection Strength
0.464
-
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. EClinicalMedicine. 2021 May; 35:100849.
Score: 0.235
-
Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety. Basic Clin Pharmacol Toxicol. 2021 Feb; 128(2):204-212.
Score: 0.229